Ortho-Clinical Diagnostics Inc.:市場シェア分析...市場調査レポートについてご紹介

【英文タイトル】Ortho-Clinical Diagnostics Inc. Market Share Analysis

▼当市場調査レポートの詳細内容確認、お問い合わせ及びご購入申込は下記ページでお願いします。▼マーケットレポート

【レポートの概要(一部)】

1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 7
1.2 List of Figures 8
2 Introduction 10
2.1 What Is This Report About? 10
3 Definitions of Markets/Categories Covered 11
3.1 In Vitro Diagnostics 11
3.1.1 Clinical Chemistry 11
3.1.2 Immuno Chemistry 11
4 Company Snapshot 12
4.1 Key Information 12
4.2 Company Overview 12
4.3 SWOT Snapshot 12
4.4 Business Overview 13
4.5 Major Products and Services 14
4.5.1 Overview 14
5 History 15
6 SWOT Analysis 18
6.1 Overview 18
6.2 Ortho-Clinical Diagnostics Inc. Strengths 18
6.2.1 IVD Product Portfolio 18
6.2.2 Improving Market Share in Global IVD Segment 18
6.2.3 The VITROS Family of Systems 19
6.3 Ortho-Clinical Diagnostics Inc. Weaknesses 19
6.3.1 Product Recalls 19
6.4 Ortho-Clinical Diagnostics Inc. Opportunities 19
6.4.1 Public-Private Partnership: US and China 19
6.4.2 Product Pipeline and New Product Launches 19
6.4.3 Expansion Strategy 20
6.5 Ortho-Clinical Diagnostics Inc. Threats 20
6.5.1 Increasing Competition 20
6.5.2 Regulatory Environment 20
6.5.3 Evolving Technological Environment 20
7 Competitors 21
8 Competitive Landscape 22
8.1 In Vitro Diagnostics(Clinical Chemistry), Global, Market Share (%), 2011 22
8.2 Ortho-Clinical Diagnostics Inc., In Vitro Diagnostics(Clinical Chemistry)by Region, Market Share (2011) 23
8.3 Ortho-Clinical Diagnostics Inc., In Vitro Diagnostics(Clinical Chemistry), by Country, Market Share (2011) 24
8.4 In Vitro Diagnostics(Immuno Chemistry), Global, Market Share (%), 2011 26
8.5 Ortho-Clinical Diagnostics Inc., In Vitro Diagnostics(Immuno Chemistry), by Region, Market Share (2011) 28
8.6 Ortho-Clinical Diagnostics Inc., In Vitro Diagnostics(Immuno Chemistry), by Country, Market Share (2011) 29
9 Ortho-Clinical Diagnostics Inc Medical Equipment Market Share Analysis by Category 31
9.1 Ortho-Clinical Diagnostics Inc., In Vitro Diagnostics, Global, Category Revenue Share (2011) 31
9.2 Ortho-Clinical Diagnostics Inc., Asia-Pacific, Category Revenue Share (2011) 33
9.2.1 Ortho-Clinical Diagnostics Inc., Australia, Category Revenue Share (2011) 35
9.2.2 Ortho-Clinical Diagnostics Inc., China, Category Revenue Share (2011) 37
9.2.3 Ortho-Clinical Diagnostics Inc., India, Category Revenue Share (2011) 39
9.2.4 Ortho-Clinical Diagnostics Inc., Japan, Category Revenue Share (2011) 41
9.2.5 Ortho-Clinical Diagnostics Inc., Other Asia-Pacific, Category Revenue Share (2011) 43
9.3 Ortho-Clinical Diagnostics Inc., Europe, Category Revenue Share (2011) 45
9.3.1 Ortho-Clinical Diagnostics Inc., France, Category Revenue Share (2011) 47
9.3.2 Ortho-Clinical Diagnostics Inc., Germany, Category Revenue Share (2011) 49
9.3.3 Ortho-Clinical Diagnostics Inc., Italy, Category Revenue Share (2011) 51
9.3.4 Ortho-Clinical Diagnostics Inc., Spain, Category Revenue Share (2011) 53
9.3.5 Ortho-Clinical Diagnostics Inc., United Kingdom, Category Revenue Share (2011) 55
9.3.6 Ortho-Clinical Diagnostics Inc., Other Europe, Category Revenue Share (2011) 57
9.4 Ortho-Clinical Diagnostics Inc., Middle East and Africa, Category Revenue Share (2011) 58
9.5 Ortho-Clinical Diagnostics Inc., North America, Category Revenue Share (2011) 61
9.5.1 Ortho-Clinical Diagnostics Inc., Canada, Category Revenue Share (2011) 63
9.5.2 Ortho-Clinical Diagnostics Inc., United States, Category Revenue Share (2011) 65
9.6 Ortho-Clinical Diagnostics Inc., South and Central America, Category Revenue Share (2011) 67
9.6.1 Ortho-Clinical Diagnostics Inc., Brazil, Category Revenue Share (2011) 69
9.6.2 Ortho-Clinical Diagnostics Inc., Other South and Central America, Category Revenue Share (2011) 71
10 Key Employees 73
11 Company Statement 74
12 Locations And Subsidiaries 75
12.1 Head Office 75
12.2 Other Locations & Subsidiaries 75
13 Financial Deals Landscape 77
13.1 Ortho-Clinical Diagnostics Inc., Deals Volume Summary, 2007 to YTD 2013 77
14 Ortho-Clinical Diagnostics Inc. Detailed Deal Summary 79
14.1 Private Equity 79
14.1.1 Gores Completes Acquisition Of Therakos From Ortho-Clinical Diagnostics 79
14.2 Partnerships 81
14.2.1 Intrinsic Bioprobes Enters Into Licensing Agreement With Ortho-Clinical Diagnostics 81
14.2.2 CeMines Enters Into An Agreement With Ortho-Clinical Diagnostics 82
14.2.3 20/20 GeneSystems Signs An Agreement With Ortho-Clinical Diagnostics 83
14.2.4 Roche Signs Licensing Agreement With Ortho-Clinical Diagnostics And Novartis Vaccines and Diagnostics 84
14.2.5 QIAGEN And Ortho-Clinical Diagnostics Enter Into Licensing Agreement 85
14.2.6 Bristol-Myers Squibb, Saladax Biomedical And Ortho-Clinical Diagnostics Expand Co-Development Agreement 86
14.2.7 Rapid Biosensor Announces Option Agreement With Ortho-Clinical Diagnostics 88
14.3 Asset Transactions 89
14.3.1 Streck Acquires SickleDex Product Line From Ortho-Clinical Diagnostics 89
15 Recent Developments 90
15.1 Product News 90
15.1.1 Jun 11, 2012: Ortho-Clinical Receives CE Mark For VITROS Immunodiagnostic Free PSA Assay 90
15.1.2 Jun 04, 2012: Ortho Clinical Diagnostics Receives CE Mark For Vitamin D Total Assay 90
15.1.3 Mar 28, 2012: Ortho-Clinical Announces Availability Of Avioq HTLV-I/II Microelisa System Assay 91
15.1.4 Mar 27, 2012: Avioq Receives FDA Approval For HTLV-I/II Microelisa System 91
15.1.5 Jul 22, 2011: Ortho Clinical Diagnostics Launches VITROS 4600 Chemistry System For Mid-To High-Volume Laboratories 92
15.1.6 Nov 01, 2010: Ortho Clinical Diagnostics Receives FDA 510(k) Clearance For VITROS Intact Parathyroid Hormone Assay 93
15.1.7 Nov 01, 2010: Ortho-Clinical Diagnostics Gets FDA Clearance For VITROS Intact Parathyroid Hormone (iPTH) Assay 93
15.1.8 Oct 26, 2009: Ortho Clinical Diagnostics Receives FDA Approval For VITROS Hepatitis B Surface Antigen (HBsAg) Assay 94
15.1.9 Oct 23, 2009: Ortho Clinical Diagnostics Introduces FETALSCREEN II Fetal Maternal Hemorrhage Screening Test 95
15.1.10 Oct 14, 2009: Ortho Clinical Diagnostics Announces FDA Approval For Diagnostic Assay For Detection Of HIV Types 1+2 For Use With VITROS 5600 Integrated And VITROS 3600 Immunodiagnostic Systems 95
15.1.11 Jul 21, 2009: Ortho Clinical Diagnostics Announces US FDA Approval Of The VITROS Anti-HCV Assay For Use On The VITROS 5600 Integrated And 3600 Immunodiagnostic Systems 96
15.1.12 Jan 15, 2009: Ortho Clinical Diagnostics Announces Availability Of Two Next Generation Clinical Diagnostic Platforms In Europe 96
15.1.13 Dec 23, 2008: Ortho Clinical’s VITROS 3600 Immunodiagnostic System Receives 510 (K) Clearance For Laboratory Diagnostics 97
15.1.14 Oct 01, 2007: Ortho-Clinical Diagnostics Introduces Improved Sensitivity Troponin I Assay 97
15.1.15 Jun 04, 2007: Ortho-Clinical Diagnostics Expands Infectious-Disease Test Menu With Launch of Toxoplasma IgM Assay 98
15.1.16 Jun 04, 2007: Ortho-Clinical Diagnostics Expands Infectious-Disease Test Menu With Launch of CMV IgG Assay 98
15.1.17 Jun 04, 2007: Ortho-Clinical Diagnostics Expands Infectious-Disease Test Menu With Launch of Rubella IgM Assay 99
15.2 Product Approvals 99
15.2.1 Jun 11, 2012: Ortho-Clinical Receives CE Mark For VITROS Immunodiagnostic Free PSA Assay 99
15.2.2 Jun 04, 2012: Ortho Clinical Diagnostics Receives CE Mark For Vitamin D Total Assay 99
15.2.3 Mar 27, 2012: Avioq Receives FDA Approval For HTLV-I/II Microelisa System 100
15.2.4 Nov 01, 2010: Ortho Clinical Diagnostics Receives FDA 510(k) Clearance For VITROS Intact Parathyroid Hormone Assay 101
15.2.5 Nov 01, 2010: Ortho-Clinical Diagnostics Gets FDA Clearance For VITROS Intact Parathyroid Hormone (iPTH) Assay 101
15.2.6 Oct 26, 2009: Ortho Clinical Diagnostics Receives FDA Approval For VITROS Hepatitis B Surface Antigen (HBsAg) Assay 102
15.2.7 Oct 14, 2009: Ortho Clinical Diagnostics Announces FDA Approval For Diagnostic Assay For Detection Of HIV Types 1+2 For Use With VITROS 5600 Integrated And VITROS 3600 Immunodiagnostic Systems 103
15.2.8 Oct 14, 2009: Ortho Clinical Diagnostics Announces FDA Approval For Diagnostic Assay For Detection Of HIV Types 1+2 For Use With VITROS 5600 Integrated And VITROS 3600 Immunodiagnostic Systems 103
15.2.9 Jul 21, 2009: Ortho Clinical Diagnostics Announces US FDA Approval Of The VITROS Anti-HCV Assay For Use On The VITROS 5600 Integrated And 3600 Immunodiagnostic Systems 104
15.2.10 Dec 23, 2008: Ortho Clinical’s VITROS 3600 Immunodiagnostic System Receives 510 (K) Clearance For Laboratory Diagnostics 105
15.3 Other Significant Developments 105
15.3.1 Mar 25, 2010: Ortho-Clinical Diagnostics To Break Ground On Solar Energy Installation At New Jersey Headquarters 105
16 Appendix 107
16.1 Research Methodology 108
16.2 Secondary Research 108
16.3 Primary Research 108
16.4 Models 109
16.5 Forecasts 109
16.6 Expert Panels 109
16.7 GlobalData Consulting 109
16.8 Currency Conversion 110
16.9 Contact Us 111
16.10 Disclaimer 111


【レポート販売概要】

■ タイトル:Ortho-Clinical Diagnostics Inc.:市場シェア分析
■ 英文:Ortho-Clinical Diagnostics Inc. Market Share Analysis
■ 発行日:2013年2月28日
■ 調査会社:GlobalData
■ 商品コード:GDATA403160532
■ 調査対象地域:グローバル
※当サイトは世界の市場調査レポート紹介サイトです。市場規模、市場動向、市場予測など、多様な分析データを含むグローバル調査レポートをご案内致します。日本国内を含むアジア太平洋、中国、ヨーロッパ、アメリカ、北米、中南米、中東、アフリカ地域などにおける、製品、サービス、技術、企業(メーカー、ベンダー)、市場シェア、市場環境など多様な項目に対応致します。当サイトでご紹介するレポートは「市場調査レポート販売サイトのMarketReport.jp」でお問い合わせ及びご購入可能です。